Stay updated on OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Sign up to get notified when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.

Latest updates to the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check14 days agoChange DetectedRemoved the term Uterine leiomyoma. Removed the Genetic and Rare Diseases Information Center resource from the resources section.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2. This change does not affect page content or functionality.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded the term Uterine leiomyoma and a Genetic and Rare Diseases Information Center resource in the Resources section.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous Revision: v3.4.1 notice and the government funding status notice.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded a government funding lapse notice and updated the page revision to v3.4.1; removed the previous revision v3.4.0.SummaryDifference0.2%

Stay in the know with updates to OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OBE2109 Efficacy in Heavy Menstrual Bleeding Clinical Trial page.